AstraZeneca Hits Back At Teva In Diabetes Drug Patent Feud
Pharmaceutical giant AstraZeneca has asked a London court to throw out generics specialist Teva's bid to nix its expired patent and soon-to-expire supplementary protection certificates for a diabetes drug....To view the full article, register now.
Already a subscriber? Click here to view full article